Tormere Analytics
Overview
Stock Research
Portfolio Lab
Options Lab
Watchlist
Screener
Convergence
Data Explorer
Learn
Newsletter
Pricing
Developer
Loading portfolio…
TRV GP IV, LLC | Tormere
← Big Money
TRV GP IV, LLC
Est. AUM
$266.9M
13F long equity, this entity only
Positions
2
Period
Mar 2026 (Q1)
SEC EDGAR
View filings ↗
Current Holdings
What Changed
Pro
Mar 2026 (Q1)
All
2
Long Equity
2
#
Issuer
Class
Value
Shares
% Portfolio
Discretion
1
MAZE THERAPEUTICS, INC.
COM
$133.5M
4473958
50.04%
SOLE
2
TANGO THERAPEUTICS, INC.
COM
$133.4M
6374574
49.96%
SOLE
Values in USD (reported in $thousands on 13F). Source: SEC EDGAR.
